Literature DB >> 2895151

Aerobactin-mediated uptake of iron by strains of Escherichia coli causing acute pyelonephritis and bacteraemia.

S H Jacobson1, K Tullus, B Wretlind, A Brauner.   

Abstract

A total of 285 strains of Escherichia coli isolated from children and women with acute non-obstructive pyelonephritis and from patients with bacteraemia as well as 120 faecal strains of E. coli from healthy children and adults were examined for aerobactin-mediated uptake of iron. The incidence of aerobactin-positive strains was significantly more in isolates from children with acute pyelonephritis (81%) than in faecal isolates from healthy children (50%, P less than 0.01). It was also higher in isolates of E. coli from women with acute pyelonephritis (72%) compared with faecal isolates from healthy adults (42%, P less than 0.001). Of the E. coli strains causing bacteraemia, 55% were aerobactin-positive. A significant correlation was found between the presence of aerobactin and expression of P-fimbriae in strains of E. coli isolated from children with acute pyelonephritis (P less than 0.01) and in isolates from bacteraemic patients (P less than 0.001). These results indicate that the presence of an aerobactin-mediated system of iron uptake may be an important virulence factor in strains of E. coli that cause ascending pyelonephritis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2895151     DOI: 10.1016/s0163-4453(88)93947-3

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  10 in total

1.  Production of cytotoxic necrotizing factor, verocytotoxin and haemolysin by pyelonephritogenic Escherichia coli.

Authors:  A Brauner; M Katouli; K Tullus; S H Jacobson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-10       Impact factor: 3.267

2.  Incidence of aerobactin-positive Escherichia coli strains in patients with symptomatic urinary tract infection.

Authors:  S H Jacobson; M Hammarlind; K J Lidefeldt; E Osterberg; K Tullus; A Brauner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-10       Impact factor: 3.267

3.  Escherichia coli populations from diabetic and non-diabetic patients with bacteraemia and faecal samples from healthy subjects--a comparative study.

Authors:  A Brauner; B Hylander; B Wretlind; C G Ostenson; I Kühn
Journal:  Epidemiol Infect       Date:  1990-12       Impact factor: 2.451

4.  Virulence genotype and phylogenetic groups in relation to Chinese herb resistance among Escherichia coli from patients with acute pyelonephritis.

Authors:  YanQing Tong; ShuQing Sun; Ying Chi
Journal:  Afr J Tradit Complement Altern Med       Date:  2014-04-03

5.  Prevalence of virulence genes and clonality in Escherichia coli strains that cause bacteremia in cancer patients.

Authors:  F Hilali; R Ruimy; P Saulnier; C Barnabé; C Lebouguénec; M Tibayrenc; A Andremont
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

Review 6.  Virulence factors in Escherichia coli urinary tract infection.

Authors:  J R Johnson
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

Review 7.  Immunomodulation therapy offers new molecular strategies to treat UTI.

Authors:  Daniel Butler; Ines Ambite; Murphy Lam Yim Wan; Thi Hien Tran; Björn Wullt; Catharina Svanborg
Journal:  Nat Rev Urol       Date:  2022-06-22       Impact factor: 16.430

Review 8.  Antimicrobial mechanisms of the urinary tract.

Authors:  Milan Chromek; Annelie Brauner
Journal:  J Mol Med (Berl)       Date:  2007-09-06       Impact factor: 4.599

9.  Role of aerobactin in systemic spread of an opportunistic strain of Escherichia coli from the intestinal tract of gnotobiotic lambs.

Authors:  M Der Vartanian; B Jaffeux; M Contrepois; M Chavarot; J P Girardeau; Y Bertin; C Martin
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

Review 10.  Molecular determinants of disease severity in urinary tract infection.

Authors:  Ines Ambite; Daniel Butler; Murphy Lam Yim Wan; Therese Rosenblad; Thi Hien Tran; Sing Ming Chao; Catharina Svanborg
Journal:  Nat Rev Urol       Date:  2021-06-15       Impact factor: 14.432

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.